Oppenheimer keeps Outperform on ESAB but cuts target to $110
Oppenheimer maintained Outperform on ESAB, cutting its target to $110 from $135, and kept IDEX at Outperform with its target raised to $275.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Oppenheimer analysts kept their Outperform rating on ESAB shares but lowered the price target to $110 per share from $135. The move was reported by Dow Jones Newswires, citing ratings data from Benzinga.
For IDEX, Oppenheimer also held its Outperform recommendation, while raising the price target to $275 from $270 per share. Both decisions were published at the same time, on October 21, 2026.
why it matters
Analyst price target changes are a routine part of coverage of individual stocks. Cutting the ESAB target while keeping the rating signals a more cautious view of the shares, while the small IDEX increase more likely reflects a model adjustment than a change of view on the company. For the broader market, such news usually carries limited weight.
tags
instruments
sources
- ESAB Is Maintained at Outperform by Oppenheimer — Dow Jones Newswires, 21 October 2026 at 17:14 UTC
- IDEX Is Maintained at Outperform by Oppenheimer — Dow Jones Newswires, 21 October 2026 at 17:14 UTC
- SPX Technologies Is Maintained at Outperform by Oppenheimer — Dow Jones Newswires, 21 October 2026 at 17:20 UTC
- Pentair Is Maintained at Outperform by Oppenheimer — Dow Jones Newswires, 21 October 2026 at 17:18 UTC
- Twilio Is Maintained at Outperform by Oppenheimer — Dow Jones Newswires, 21 October 2026 at 17:21 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗